US Stock MarketDetailed Quotes

XLO Xilio Therapeutics

Watchlist
  • 1.120
  • +0.030+2.75%
Close May 15 16:00 ET
  • 1.140
  • +0.020+1.79%
Post 19:37 ET
41.34MMarket Cap-435P/E (TTM)

Xilio Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Xilio Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.64

+21.95%
Analyst Rating

No Data

Xilio Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 30.000M--
--2024/Q10.000 / 10.000M--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 30.000M--
--2024/Q10.000 / 10.000M--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Xilio Therapeutics Earnings Reports

  • Xilio Therapeutics | 10-Q: Quarterly report

    May 14 20:14

  • Xilio Therapeutics | 10-K: Annual report

    Apr 2 04:27

  • Xilio Therapeutics | 10-Q: Quarterly report

    Nov 10, 2023 05:17

  • Xilio Therapeutics | 10-Q/A: Quarterly report (Amendment)

    Nov 10, 2023 05:10

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg